Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

SCAI: Transradial program may require time investment, but 'worth it'

San Diego -- When launching a program to train cardiologists in the radial technique, cardiac cath labs should be prepared to face logistical challenges for a substantial period of time, despite the safety and comfort benefits to the patient, based on a case study presented Wednesday at the Society for Cardiovascular Angiography and Interventions (SCAI) 33rd annual scientific sessions.

SCAI: Radial approach challenges PCI discharge guidelines

San Diego -- Recently published SCAI/ACC guidelines for appropriate same-day PCI may not accurately reflect what is possible in real-world U.S. practice using standard transradial approaches, according to a study presented Wednesday at the Society for Cardiovascular Angiography and Interventions (SCAI) 33rd annual scientific sessions.

Cardiovascular Systems completes enrollment in CALCIUM 360 trial

Cardiovascular Systems has completed patient enrollment in its prospective, randomized CALCIUM 360 clinical trial, part of the companys 360 clinical series.

FDA warns prostate cancer drugs linked with diabetes, MI

Gonadotropin-Releasing Hormone (GnRH) agonists, a class of medications primarily used to treat men with prostate cancer, have been associated with a small increased risk for diabetes, heart attack, stroke and sudden death in men treated with one of the medications, according to an ongoing analysis of several studies by the FDA.

Maquet launches pressure control syringe for CABG

Maquet Cardiovascular has launched its Vasoshield pressure controlling syringe that limits flushing pressure and controls vessel distension to maintain internal vessel reliability during CABG.

CRF: Two-stents may be beneficial during complex left branch PCI

During complex left branch bifurcation, utilizing a two-stent technique may be a fruitful, simple approach to treat certain subtypes of coronary bifurcation stenting, said Antonio Colombo, MD, of the Centro Cuore and San Raffaele Hospital in Milan, Italy, during a presentation at the fourth annual Left Main and Bifurcation Summit April 29 in Seoul, South Korea, sponsored by the Cardiovascular Research Foundation.

CCI: Mortality higher in CAD patients who undergo partial revascularization

For patients with coronary artery disease (CAD) who cannot undergo full revascularization, mortality rates are significantly higher and researchers say more treatment options need to be made available for this patient cohort, according to a study published May 1 in Catheterization and Cardiovascular Interventions.

Spectranetics Q1 net loss narrows on higher revenues

Spectranetics has reported narrowed losses for its financial results for the 2010 first quarter, which ended March 31.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.